Next Generation Migraine Therapies

American headache Society

Next Generation Migraine Therapies 

SALT LAKE CITY  CHICAGO • Seattle

Our spring 2020 NGMT sessions were postponed due to COVID-19 to protect the safety and well-being of faculty, attendees and staff. If you registered for a spring session and would like to attend the rescheduled session, please re-register. 

The programs have been rescheduled for the following dates:

Dates and Cities: 

Salt Lake City, UT – September 12, 2020
Chicago, IL – September 26, 2020
Seattle, WA – October 31, 2020

The Next Generation Migraine Therapies (NGMT) will highlight recent updated epidemiological data on the scope and distribution of Episodic and Chronic Migraine, practical methods for diagnosing Migraine, recent insights into mechanisms, and new therapeutic options for the prevention and treatment of migraine.

Who Should Attend

This program is designed for Neurologists, Family Practitioners, Internists and other health professionals who would like more information on the proper diagnosis and treatment of chronic migraine patients.

Educational Objectives

  • Recognize the lack of awareness of the basic science and therapeutic potential of CGRP mAbs in the prevention of migraine.
  • Identify mAbs, particularly CGRP and its receptor, provide effective prophylaxis of migraine.
  • Address the need for greater understanding of how to apply new information about migraine pathophysiology to specific patients and potential treatments.
  • Review data on the effectiveness and safety of mAbs in the treatment of migraine and learn how results in key sub-populations can help them predict which patients are likely to respond to treatment with CGRP mAbs.

CME Statement

AHS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. AHS takes responsibility for the content, quality, and scientific integrity of this CME activity. 

The American Headache Society® designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credit(s)™; 4.0 AMA PRA Category 1 Credit(s)™ for the morning program and 3.50 AMA PRA Category 1 Credit(s)™ for the afternoon program. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAFP

This Live activity, Next Generation Migraine Therapies, from 09/12/2020 - 10/31/2020, has been reviewed and is acceptable for up to 8.25 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact:

AHS Headquarters
ahshq@talley.com
856-423-0043

Online registration closes 5 days before the event date. On-site registration is available but advanced registration is highly recommended.